A group of 56 patients who had received sustained, systemic corticosteroid therapy were
examined in order to determine the incidence of posterior subcapsular cataracts. Thirty-eight …

IN MAY, 1960, the rheumatologists of this group were contacted by Black and Bunim
concerning their study then in progress, which revealed a 39 per cent incidence of posterior …

A previous report by us 1 has detailed the occurrence of posterior subcapsular cataracts
(PSC) in 5 of 22 (23%) rheumatoid arthritis patients treated with 10-16 mg. of prednisone or …

A previous communication by the authors related the development of posterior subcapsular
cataracts (PSC) to long-term high dose corticosteroid therapy, 1 and a subsequent paper 2 …

• While the cataractogenic effects of corticosteroids are beyond dispute, disagreement exists
concerning effects of total dose, intensity of dose, and duration of administration on cataract …

Centrally placed opacities lying under the capsuleatthe posteriorpart of the lens-posterior
subcapsular cataracts (PSC)-have beenreported in 12.5 to 6o per cent.(mean 36-7 per cent.) …

The presumed association of lens opacifications and prolonged corticosteroid therapy was
first reported by Black, Oglesby, Von Sallmann and Bunim in I960, 1 and later reaffirmed by …

POSTERIOR subcapsular cataracts (PSC) are generally associated with exposure to toxic
agents, posterior intraocular disease, ionizing radiation, or blunt trauma. As a rule these …

RESULTS General findings. During betamethasone administration there was no gain of
weight, and after 41 weeks the four surviving rabbits still weighed about 2.5 kg. One of the …

In 1960 Black et al.(1, 2) reported that they had found among patients with rheumatoid
arthritis, who had received long-term general corticosteroid treatment in moderately-high …